Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
11.41
-0.18 (-1.55%)
Nov 20, 2024, 4:00 PM EST - Market closed

Bioventus Revenue

Bioventus had revenue of $138.96M in the quarter ending September 28, 2024, with 15.04% growth. This brings the company's revenue in the last twelve months to $555.06M, up 10.40% year-over-year. In the year 2023, Bioventus had annual revenue of $512.35M with 0.04% growth.

Revenue (ttm)
$555.06M
Revenue Growth
+10.40%
P/S Ratio
1.31
Revenue / Employee
$572,228
Employees
970
Market Cap
745.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023512.35M228.00K0.04%
Dec 31, 2022512.12M81.22M18.85%
Dec 31, 2021430.90M109.74M34.17%
Dec 31, 2020321.16M-18.98M-5.58%
Dec 31, 2019340.14M20.96M6.57%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.12B
Orthofix Medical 784.25M
Pacira BioSciences 694.96M
Avanos Medical 681.50M
Prothena Corporation 133.35M
Cronos Group 111.23M
Revenue Rankings